← back to search

Barbara Guarino

Vir Biotechnology (Switzerland) · CH
Area of research
Infectious Diseases · Animal Science and Zoology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, Viral gastroenteritis research and epidemiology, and Monoclonal and Polyclonal Antibodies Research.
h-index
25
citations
8,744
works
41
NIH funding
primary concept
Biology
email

Recent publications

A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification
Cell 2024cited by 63position: middledoi
Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses
Immunity 2024cited by 6position: middledoi
Neutralization, effector function and immune imprinting of Omicron variants
Nature 2023cited by 178position: middledoi
A pan-influenza antibody inhibiting neuraminidase via receptor mimicry
Nature 2023cited by 92position: middledoi
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Science 2022cited by 255position: middledoi
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
Science 2022cited by 162position: middledoi
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Cell 2021cited by 1,013position: middledoi
Broad betacoronavirus neutralization by a stem helix–specific human antibody
Science 2021cited by 429position: middledoi
Broad sarbecovirus neutralization by a human monoclonal antibody
Nature 2021cited by 315position: middledoi
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Nature 2020cited by 2,138position: middledoi
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Cell 2020cited by 1,623position: middledoi
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
Science 2020cited by 625position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Young‐Jun Park · Howard Hughes Medical Institute2 papers (2020–2024)David Veesler · Howard Hughes Medical Institute2 papers (2020–2024)Davide Corti · Vir Biotechnology (Switzerland)2 papers (2020–2024)Katja Culap · Vir Biotechnology (Switzerland)2 papers (2020–2024)M. Alejandra Tortorici · University of Washington2 papers (2020–2024)Anna De Marco · Vir Biotechnology (Switzerland)1 papers (2020–2020)Stefano Jaconi · Vir Biotechnology (Switzerland)1 papers (2020–2020)Martina Beltramello · Vir Biotechnology (Switzerland)1 papers (2020–2020) · 1 papers (2024–2024)Fabio Benigni · Vir Biotechnology (Switzerland)1 papers (2024–2024)Rita E. Chen · Saint Louis University1 papers (2020–2020)Antonio Lanzavecchia · Vir Biotechnology (Switzerland)1 papers (2020–2020)Dora Pinto · Vir Biotechnology (Switzerland)1 papers (2020–2020)Siro Bianchi · Vir Biotechnology (Switzerland)1 papers (2020–2020)Amalio Telenti · Scripps Institution of Oceanography1 papers (2020–2020)Michael Diamond · Infectious Disease Research Institute1 papers (2020–2020)Miles Sasha Dickinson · University of San Francisco1 papers (2024–2024)Roberto Spreafico · Genmab (United States)1 papers (2020–2020)Elisabetta Cameroni · Vir Biotechnology (Switzerland)1 papers (2020–2020)Daniel Asarnow · University of Washington1 papers (2024–2024)